Rxo Debt-to-Equity Ratio Growth & History (RXO)
Rxo's debt-to-equity ratio was 0.43 for fiscal 2025.
View full Rxo company overviewRxo annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.43 | 0.02 | +5.55% |
| 2024 | 2024-12-31 | 0.41 | −0.53 | −56.15% |
| 2023 | 2023-12-31 | 0.94 | −0.11 | −10.63% |
| 2022 | 2022-12-31 | 1.05 | 0.92 | +733.10% |
| 2021 | 2021-12-31 | 0.13 | — | — |
Rxo quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.48 | 0.06 | +13.05% |
| Q1 2026 | 2026-03-31 | 0.46 | 0.03 | +7.32% |
| Q4 2025 | 2025-12-31 | 0.43 | 0.02 | +5.55% |
| Q3 2025 | 2025-09-30 | 0.43 | 0.01 | +1.43% |
| Q2 2025 | 2025-06-30 | 0.43 | −0.61 | −58.74% |
| Q1 2025 | 2025-03-31 | 0.43 | −0.55 | −56.01% |
| Q4 2024 | 2024-12-31 | 0.41 | −0.53 | −56.15% |
| Q3 2024 | 2024-09-30 | 0.43 | −0.64 | −60.08% |
| Q2 2024 | 2024-06-30 | 1.04 | −0.02 | −1.71% |
| Q1 2024 | 2024-03-31 | 0.98 | −0.06 | −5.91% |
| Q4 2023 | 2023-12-31 | 0.94 | −0.11 | −10.63% |
| Q3 2023 | 2023-09-30 | 1.07 | 0.92 | +609.08% |
| Q2 2023 | 2023-06-30 | 1.05 | — | — |
| Q1 2023 | 2023-03-31 | 1.04 | — | — |
| Q4 2022 | 2022-12-31 | 1.05 | 0.92 | +733.10% |
| Q3 2022 | 2022-09-30 | 0.15 | — | — |
| Q4 2021 | 2021-12-31 | 0.13 | — | — |
Rxo debt-to-equity ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Rxo's debt-to-equity ratio increased from 0.13 to 0.43, a change of 0.31. The latest reported quarter, Q2 2026, shows 0.48.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rxo source filings ↗